Cerevance To Focus On Parkinson’s Adjunctive Therapy After Phase II Miss

 
• By Joseph Haas
  
Human Hands Holding Brain Anatomy And Missing A Piece, Of Jigsaw
Cerevance takes a Phase II setback with its novel mechanism for Parkinson's disease (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Therapy Areas